Celmatix Inc. is a preclinical-stage women’s health biotech focused uniquely on ovarian biology. With a lead “pipeline-in-a-pill” AMHR2 program focused on ovarian senescence, and collaborations in PCOS and non-hormonal contraception with industry leaders, Celmatix is addressing areas of high unmet need by developing the next generation of interventions and pioneering advancements in ovarian health.

Biotechnology

Celmatix

Piraye Yurttas Beim

Robert O'Connell

Charlotte Frank Sage

Adrienne Day

Herman Lau

Craig Bolton

Stephen Palmer

Caterina Clementi

Leadership Team

Scientific Advisory Team

Teams at Celmatix

Leadership Team

Scientific Advisory Team